Showing 261-270 of 350 grants

Title Institution Researcher Program Duration Total Award Amount
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750.000,00
Studies of Promising Functional Endpoints in Eyes of Patients with Diabetes (Protocols AR and AS ) Jaeb Center for Health Research Adam Glassman Improving Lives 01-May-2026 to 30-April-2030 $1.035.583,00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850.000,00
Adult T1D Detection at Geisinger IQVIA, Inc. Nadejda Leavitt Cures 01-July-2023 to 30-June-2027 $1.033.123,00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-October-2026 $345.083,00
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog Invictus Therapeutics, LLC Robyn Day Improving Lives 15-October-2025 to 31-May-2027 $1.437.112,00
A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening Indiana Biosciences Research Institute Roberto Mallone Cures 01-June-2026 to 31-May-2027 $196.040,47
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748.169,00
Defining antigen-presenting cell – CD8 T cell crosstalk in type 1 diabetes using uLIPSTIC Icahn School of Medicine at Mount Sinai Verena van der Heide Cures 01-May-2026 to 30-April-2029 $600.000,00
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 30-September-2026 $199.998,24